Facebook Pixel Code
About Sickkids
About SickKids

May 10, 2010

Scherer to lead genomic medicine program

One of The Hospital for Sick Children’s (SickKids) renowned geneticists has just been announced as the new Director of the McLaughlin Centre (previously known as the McLaughlin Centre for Molecular Medicine). Dr. Steve Scherer, the Director of The Centre for Applied Genomics and a Senior Scientist in Genetics & Genome Biology at SickKids, will work with the McLaughlin Centre’s fellows to further genomic medicine through research and education.

Established in 2000 with a $50-million bequest from R. Samuel McLaughlin Foundation, the McLaughlin Centre is at the forefront of genomic medicine, much like Scherer himself. His team has contributed to discoveries of global gene copy number variation (CNV) revealing CNV to be the most abundant type of nucleotide variation of human DNA. They also found CNV contributes to the etiology of autism. The McLaughlin Centre-supported Database of Genomic Variants he founded facilitates thousands of diagnoses each year.

“The time is right to bring to bear the strengths of the Toronto academic health science community to advance genomic medicine in Canada and abroad,” said Scherer, who also holds the GlaxoSmithKline-CIHR Endowed Chair in Genetics and Genomics at SickKids and University of Toronto, about his appointment. With this new position he hopes to work with other prominent institutions, like the McLaughlin-Rotman Centre for Global Health, The Centre for Applied Genomics and the Ontario Genomics Institute, to further genomic medicine. “If the formula includes excellence and impact in genomic medicine, we will want to be involved.”